For example, HER2 overexpression has been observed in subsets of patients with cancers such as breast and gastric cancer, but a HER2 inhibitor, pertuzumab, is more effective in treating HER2-positive breast cancer compared to HER2-positive gastric cancer10. This evidence concerns the gene ERBB2 and cancer.